Literature DB >> 11720698

Strengthening clinical effectiveness trials: equipoise-stratified randomization.

P W Lavori1, A J Rush, S R Wisniewski, J Alpert, M Fava, D J Kupfer, A Nierenberg, F M Quitkin, H A Sackeim, M E Thase, M Trivedi.   

Abstract

As psychiatric practice patterns evolve to take advantage of the growing list of treatments with proven efficacy, research studies with broader aims will become increasingly important. Randomized trials may need to accommodate multiple treatment options. In completely randomized designs, patients are assigned at random to one of the options, requiring that patients and clinicians find each of the options acceptable. In "clinician's choice" designs, patients are randomized to a small number of broad strategies and the choice of specific option within the broad strategy is left up to the clinician. The clinician's choice design permits some scope to patient and clinician preferences, but sacrifices the ability to make randomization-based comparisons of specific options. We describe a new approach, which we call the "equipoise stratified" design, that merges the advantages and avoids the disadvantages of the other two designs for clinical trials. The three designs are contrasted, using the National Institute of Mental Health Sequenced Treatment Alternatives to Relieve Depression trial as an example.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11720698     DOI: 10.1016/s0006-3223(01)01223-9

Source DB:  PubMed          Journal:  Biol Psychiatry        ISSN: 0006-3223            Impact factor:   13.382


  51 in total

1.  Clinical equipoise and personal equipoise: two necessary ingredients for reducing bias in manual therapy trials.

Authors:  Chad Cook; Charles Sheets
Journal:  J Man Manip Ther       Date:  2011-02

2.  What have we learned about trial design from NIMH-funded pragmatic trials?

Authors:  John March; Helena C Kraemer; Madhukar Trivedi; John Csernansky; John Davis; Terence A Ketter; Ira D Glick
Journal:  Neuropsychopharmacology       Date:  2010-08-25       Impact factor: 7.853

3.  Challenges in addressing depression in HIV research: assessment, cultural context, and methods.

Authors:  Jane M Simoni; Steven A Safren; Lisa E Manhart; Karen Lyda; Cynthia I Grossman; Deepa Rao; Matthew J Mimiaga; Frank Y Wong; Sheryl L Catz; Michael B Blank; Ralph DiClemente; Ira B Wilson
Journal:  AIDS Behav       Date:  2011-02

Review 4.  Enhancing validity in co-occurring disorders treatment research.

Authors:  Gregory J McHugo; Robert E Drake; Mary F Brunette; Haiyi Xie; Susan M Essock; Alan I Green
Journal:  Schizophr Bull       Date:  2006-07-18       Impact factor: 9.306

5.  Integrating Decision Making and Mental Health Interventions Research: Research Directions.

Authors:  Celia E Wills; Margaret Holmes-Rovner
Journal:  Clin Psychol (New York)       Date:  2006

6.  Customizing treatment to the patient: adaptive treatment strategies.

Authors:  Susan A Murphy; L M Collins; A John Rush
Journal:  Drug Alcohol Depend       Date:  2007-03-09       Impact factor: 4.492

7.  Staged Treatment in Early Psychosis: A sequential multiple assignment randomised trial of interventions for ultra high risk of psychosis patients.

Authors:  Barnaby Nelson; G Paul Amminger; Hok Pan Yuen; Nicky Wallis; Melissa J Kerr; Lisa Dixon; Cameron Carter; Rachel Loewy; Tara A Niendam; Martha Shumway; Sarah Morris; Julie Blasioli; Patrick D McGorry
Journal:  Early Interv Psychiatry       Date:  2017-07-18       Impact factor: 2.732

8.  Sequential causal inference: application to randomized trials of adaptive treatment strategies.

Authors:  Ree Dawson; Philip W Lavori
Journal:  Stat Med       Date:  2008-05-10       Impact factor: 2.373

9.  A clinical risk stratification tool for predicting treatment resistance in major depressive disorder.

Authors:  Roy H Perlis
Journal:  Biol Psychiatry       Date:  2013-02-04       Impact factor: 13.382

Review 10.  Optimizing Placebo and Minimizing Nocebo to Reduce Pain, Catastrophizing, and Opioid Use: A Review of the Science and an Evidence-Informed Clinical Toolkit.

Authors:  Beth D Darnall; Luana Colloca
Journal:  Int Rev Neurobiol       Date:  2018-08-06       Impact factor: 3.230

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.